A comparison of international breast cancer guidelines - Do the national guidelines differ in treatment recommendations?

European Journal of Cancer

Volumn 48, Issue 1, 2012, Pages 1-11

  Wolters, R ^a   Regierer, A C ^a,b   Schwentner, L ^c   Geyer, V ^c   Possinger, K ^b   Kreienberg, R ^c   Wischnewsky, M B ^a   Wockel A ^c  

^a UNIVERSITY OF BREMEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Adjuvant therapy; Breast cancer; Clinical practice guidelines; Grade of recommendation; Level of evidence; Recommendation

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LETROZOLE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER HORMONE THERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL PRACTICE; COMPARATIVE STUDY; EVIDENCE BASED PRACTICE; GERMANY; HUMAN; INTERNATIONAL COOPERATION; MASTECTOMY; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; NATIONAL HEALTH SERVICE; POSTMENOPAUSE; PRACTICE GUIDELINE; PREMENOPAUSE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION; UNITED KINGDOM; UNITED STATES;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; FEDERAL GOVERNMENT; FEMALE; HUMANS; INTERNATIONALITY; MASTECTOMY; MEDICAL ONCOLOGY; NEOPLASM GRADING; PRACTICE GUIDELINES AS TOPIC; PROTEIN KINASE INHIBITORS; RADIOTHERAPY; RECEPTOR, ERBB-2; UNITED STATES;

EID: 83255194159     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.020     Document Type: Article

References (39)

1. S. Weinbrenner, and G. Ollenschläger Guidelines as a basis for future-oriented health care management Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51 5 2008 558 564
2. M. Lugtenberg, J.S. Burgers, and G.P. Westert Effects of evidence-based clinical practice guidelines on quality of care: a systematic review Qual Saf Health Care 18 5 2009 385 392
3. M.C. Brouwers, M.E. Kho, and G.P. Browman AGREE II: advancing guideline development, reporting and evaluation in health care J Clin Epidemiol 63 12 2010 1308 1311
4. J. Watine, B. Friedberg, and E. Nagy Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners Clin Chem 52 1 2006 65 72
5. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8(6):iii-iv, 1-72.
6. J.M. Grimshaw, and I.T. Russell Effect of clinical guidelines on medical practice. A systematic review of rigorous evaluations Lancet 342 8883 1993 1317 1322
7. C. Bahtsevani, G. Udén, and A. Willman Outcomes of evidence-based clinical practice guidelines: a systematic review Int J Technol Assess Health Care 20 4 2004 427 433
8. G. Worrall, P. Chaulk, and D. Freake The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review Can Med Assoc J 156 12 1997 1705 1712
9. A. Wöckel, D. Varga, and C. Kurzeder Effects of guideline adherence in primary breast cancer - A 5-year multicenter cohort study of 3976 patients Breast 19 2 2010 120 127
10. R. Kreienberg, I. Kopp, and U. Albert Interdisciplinary S3 Guidelines for the Diagnosis, Treatment and Follow-up Care of Breast Cancer 2008 Zuckschwerdt München
11. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Breast cancer [Internet]. 2011 [cited 2011 Jan 07]. Available from: < http://www.nccn.org >.
12. American Society of Clinical Oncology Clinical Practice Guidelines. Breast Cancer: Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer [Internet]. 2005 [cited 2010 Dec 15]. Available from: < http://www.asco.org >.
13. American Society of Clinical Oncology Clinical Practice Guidelines. Breast Cancer: Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology [Internet]. 2001 [cited 2010 Dec 15]. Available from: < http://www.asco.org >.
14. American Society of Clinical Oncology Clinical Practice Guidelines. Breast Cancer: Update on Adjuvant Endocrine Therapy for Women with Hormone Receptor-Positive Breast Cancer [Internet]. 2010 [cited 2010 Dec 15]. Available from: < http://www.asco.org >.
15. National Breast and Ovarian Cancer Centre. Clinical Practice Guidelines for Breast Cancer [Internet]. 2001 [cited 2010 Dec 15]. Available from: < http://www.nbocc.org.au >.
16. National Breast and Ovarian Cancer Centre. Recommendations for Use of Sentinel Node Biopsy in Early (operable) Breast Cancer [Internet]. 2008 [cited 2010 Dec 15]. Available from: < http://www.nbocc.org.au >.
17. National Breast and Ovarian Cancer Centre. Recommendations for Aromatase Inhibitors as Adjuvant Endocrine Therapy for Post-menopausal Women with Hormone Receptor-Positive early Breast Cancer [Internet]. 2006 [cited 2010 Dec 15]. Available from: < http://www.nbocc.org.au >.
18. National Breast and Ovarian Cancer Centre. Recommendations for use of Taxane-Containing Chemotherapy Regimens for the Treatment of Early (operable) Breast Cancer [Internet]. 2006 [cited 2010 Dec 15]. Available from: < http://www.nbocc.org.au >.
19. National Breast and Ovarian Cancer Centre. Recommendations for Use of Trastuzumab (Herceptin®) for the Treatment of HER2-Positive Breast Cancer [Internet]. 2007 [cited 2010 Dec 15]. Available from: < http://www.nbocc.org. au >.
20. Cancer Care Ontario Program in evidence-based care. Surgical Management of Early Stage Invasive Breast Cancer 1-1 PG Version 2.2003 [Internet]. 2003 [cited 2010 Dec 15]. Available from: .
21. Cancer Care Ontario Program in evidence-based care. Breast Irradiation in Women with Early-Stage Invasive Breast Cancer Following Breast Conserving Surgery 1-2 PG: January 2002 [Internet]. 2002 [cited 2010 Dec 15]. Available from: .
22. Cancer Care Ontario Program in evidence-based care. Adjuvant Systemic Therapy for Node-Negative Breast Cancer 1-8 PG May 2003 [Internet]. 2003 [cited 2010 Dec 15]. Available from: .
23. Cancer Care Ontario Program in evidence-based care. Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer 1-9 EBS July 2010 [Internet]. 2010 [cited 2010 Dec 15]. Available from: .
24. Cancer Care Ontario Program in evidence-based care. Adjuvant Taxane Therapy for Women with Early-Stage Invasive Breast Cancer 1-7 EBS December 2006 [Internet]. 2006 [cited 2010 Dec 15]. Available from: .
25. Cancer Care Ontario Program in evidence-based care. The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer 1-18 EBS February 2008 [Internet]. 2008 [cited 2010 Dec 15]. Available from: .
26. National Collaborating Centre for Cancer, National Institute of Clinical Excellence. Early and locally advanced breast cancer: diagnosis and treatment [Internet]. 2009 [cited 2010 Dec 15]. Available from: < http://www.nice.org. uk >.
27. Scottish Intercollegiate Guidelines Network. Management of breast cancer in women. A National Clinical Guideline. SIGN publication No 84 [Internet]. 2005 [cited 2010 Dec 15]. Available from:< http://www.sign.ac.uk >.
28. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen: Systematische Leilinienrecherche und -bewertung sowie Extraktion neuer und relevanter Empfehlungen für das DMP Brustkrebs, IQWiG Berichte Nr. 37 [Internet]. 2008 [cited 2010 Dec 15]. Available from: < http://www.iqwiq.de >.
29. J. Grimshaw, and I. Russell Achieving health gain through clinical guidelines. I: developing scientifically valid guidelines Qual Health Care 2 1993 243 248
30. G.P. Browman, M.N. Levine, and E.A. Mohide The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation J Clin Oncol 13 2 1995 502 512
31. ÄZQ, AWMF. Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI), Fassung 2005/2006 + Domäne 8 (2008) [Internet]. 2008 [cited 2010 Dec 15]. Available from: < http://www.delbi.de >.
32. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; (1):18-23.
33. Philipps B, Ball C, Sackett D, et al. Levels of Evidence and grades of recommendation Oxford. 2009 [Internet]. [cited 2010 Dec 15] Available from: < http://www.cebm.net/index.aspx?o=1025 >.
34. ASCO Expert Panel. ASCO Guideline Procedures Manual, Version 3.0 [Internet]. 2008 [cited 2010 Dec 15]. Available from: < http://www.asco.org >.
35. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ. Panel members. Thresholds for therapies: highlights on the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009. Ann Oncol 2009; 20:1319-29.
36. GRADE Working Group. Grading quality of evidence and strength of recommendations. Brit Med J 2004; 328(7454): 1490-94.
37. Browne D, Greenwald P, Adams-Campbell L. Public Health Democracy: US and Global Health Disparities in Breast Cancer [Internet]. 2008 [cited 2010 Dec 15]. Available from: < http://www.wilsoncenter.org/globalhealth >.
38. B. Dunn, T. Agurs-Collins, D. Browne, R. Lubet, and K. Johnson Health disparities in breast cancer: biology meets socioeconomic status Breast Cancer Res Treat 121 2 2010 281 292
39. L. Vona-Davis, and D.P. Rose The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review J Womens Health 18 6 2009 883 893